Previous 10 | Next 10 |
2024-07-11 14:19:51 ET Summary Pfizer Inc. announced today that it planned to continue development of its GLP-1 agonist weight loss drug danuglipron as a once-daily oral pill. The drug met efficacy endpoints in a Phase 2 study last year as a twice daily pill, but side effects caus...
2024-07-11 11:59:36 ET More on Tesla: Tesla: Up +62% From Our Prior Bullish Article - Is It Time To Protect? (Technical Analysis) Wall Street Lunch: Tesla's Big Bull Run Surging Stock, Struggling Core: Tesla's Mixed Signals To Investors Tesla is sized up amid...
2024-07-11 11:42:26 ET Summary Biogen Inc.'s shares have risen 20% since its first quarter earnings report, with hopes for new product launches to boost revenue. However, its Alzheimer's medicine, Leqembi, now faces new competition from Eli Lilly, and its MS franchise has various ...
2024-07-11 11:17:00 ET The S&P 500’s health care sector ( NYSEARCA: XLV ), holding a weightage of 12.12% in the S&P 500 index, saw a fall of 0.49% in Q2 and is the fifth lowest scored sector by the SA Quant rating system.... Read the full article on Seeking Alph...
2024-07-11 07:56:06 ET A majority of the Seeking Alpha community doesn’t think Tesla ( NASDAQ: TSLA ) should be dropped from the Magnificent 7, according to the latest SA Sentiment Survey , even though the EV maker is seen as the least attractive stock in the list.......
2024-07-11 07:18:20 ET Buoyed by encouraging pharmacokinetic data from an ongoing study, Pfizer ( NYSE: PFE ) has decided to proceed with the development of a once-daily formulation of its oral weight-loss drug, danuglipron.... Read the full article on Seeking Alpha ...
2024-07-11 06:00:04 ET Kerry Holford from Berenberg Bank issued a price target of $1,000.00 for LLY on 2024-07-11 04:27:00. The adjusted price target was set to $1,000.00. At the time of the announcement, LLY was trading at $939.78. The overall price target consensus is ...
2024-07-11 05:30:00 ET Large-cap U.S. stocks have been on a relentless bull run for the better part of the last two years. Despite sticky inflation, geopolitical turmoil, and historically high valuations for most major indexes, U.S. large caps have shown no signs of cooling off in 2024. ...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...
A look at the top 10 most actives in the United States Longeveron Inc. (LGVN) rose 69.0% to $4.8499 on volume of 46,980,986 shares Virpax Pharmaceuticals Inc. (VRPX) rose 161.5% to $3.0333 on volume of 46,199,502 shares Maxeon Solar Technologies Ltd. (MAXN) fell 0.6% to $0.2464 on volume ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...